The NMPA released a public notice announcing newly accepted applications for the protection of Traditional Chinese Medicine (TCM) varieties. The update includes the acceptance of a renewal application for Compound Muniziqi Granules submitted by Xinjiang Uygur Pharmaceutical Co., Ltd. The notice reinforces China’s ongoing efforts to safeguard and regulate traditional medicinal preparations.
Key Highlights:
- NMPA published a list of accepted applications for TCM variety protection
- Includes a renewal application for Compound Muniziqi Granules
- Notice issued through the National Government Service Platform
- Supports structured protection of traditional formulations and associated market rights
This update enhances Regulatory clarity around TCM variety protection and lifecycle management.
Select Mandate HA
Select Mandate Function